Tech Company Financing Transactions

Adicet Bio Funding Round

On 10/4/2019, Adicet Bio secured $80 million in Series B funding from aMoon Partners, Consensus Business Group and DSC Investment.

Transaction Overview

Company Name
Announced On
10/4/2019
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series B
Proceeds Purpose
This financing will permit Adicet to continue to develop our proprietary technology, to enter the clinic in Non-Hodgkin's Lymphoma and to advance our solid tumor programs. We are gratified with the support of the investment community.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Constitution Dr.
Menlo Park, CA 94025
USA
Phone
Undisclosed
Email Address
Overview
Adicet Bio, Inc. is a biotechnology company engaged in the design and development of cutting-edge immunotherapies for cancer and other disease indications, with a focus on novel universal immune cell therapies (uICT).
Profile
Adicet Bio LinkedIn Company Profile
Social Media
Adicet Bio Company Twitter Account
Company News
Adicet Bio News
Facebook
Adicet Bio on Facebook
YouTube
Adicet Bio on YouTube

Management Team

Title
Name
Email & Social
Chairman
Donald Santel
  Donald Santel LinkedIn Profile  Donald Santel Twitter Account  Donald Santel News  Donald Santel on Facebook
Chief Executive Officer
Anil Singhal
  Anil Singhal LinkedIn Profile  Anil Singhal Twitter Account  Anil Singhal News  Anil Singhal on Facebook
Chief Financial Officer
Brian Hogan
  Brian Hogan LinkedIn Profile  Brian Hogan Twitter Account  Brian Hogan News  Brian Hogan on Facebook
Chief Medical Officer
Francesco Galimi
  Francesco Galimi LinkedIn Profile  Francesco Galimi Twitter Account  Francesco Galimi News  Francesco Galimi on Facebook
Chief Operating Officer
Stewart Abbot
  Stewart Abbot LinkedIn Profile  Stewart Abbot Twitter Account  Stewart Abbot News  Stewart Abbot on Facebook
Founder
Aya Jakobovits
  Aya Jakobovits LinkedIn Profile  Aya Jakobovits Twitter Account  Aya Jakobovits News  Aya Jakobovits on Facebook
VP - Human Resources
Carrie Krehlik
  Carrie Krehlik LinkedIn Profile  Carrie Krehlik Twitter Account  Carrie Krehlik News  Carrie Krehlik on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/4/2019: BiomeSense venture capital transaction
Next: 10/4/2019: CoLab Software venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary